Analyst Recommendations

Needham analyst issues BUY recommendation for AMZN on February 2, 2024 11:10AM ET. The previous analyst recommendation was Buy.AMZN was trading at $171.06 at issue of the analyst...

February 2, 2024   AMZN 0.03%

KeyBanc analyst issues OVERWEIGHT recommendation for META on February 2, 2024 05:46AM ET. The previous analyst recommendation was Overweight.META was trading at $394.78 at issue of the analyst...

February 2, 2024   META -0.09%

Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX -0.65%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.72%

Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX -0.65%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.72%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.72%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.72%

RBC Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -0.72%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -0.72%